# Prevalence, breed predispositions, and culture and sensitivity results of bacterial hepatobiliary infections in dogs in the United Kingdom

**Authors:** Frederik Allan, Aarti Kathrani, Thomas Butler, Mark Dunning, Jack Lawson, Katie E McCallum, Dan O’Neill, Lucy Yuan, Sarah Tayler

PMC · DOI: 10.1093/jvimsj/aalag026 · Journal of Veterinary Internal Medicine · 2026-03-02

## TL;DR

This study found that Miniature Schnauzers and Border Terriers are more likely to get bacterial liver and bile infections in the UK, and many of the bacteria are resistant to antibiotics.

## Contribution

Identified specific breed predispositions and antibiotic resistance patterns in canine bacterial hepatobiliary infections.

## Key findings

- Miniature Schnauzers and Border Terriers are significantly predisposed to bacterial hepatobiliary infections.
- Escherichia coli and Enterococcus species were the most common bacteria isolated from infections.
- Over 40% of bacterial isolates were multidrug resistant at first detection.

## Abstract

Breed predispositions for bacterial hepatobiliary infections have not been established.

To determine prevalence of bacterial hepatobiliary infections in dogs presenting to referral hospitals in the United Kingdom, ascertain whether specific breed predispositions exist, and to identify associated bacterial species.

One hundred twenty-six client-owned dogs diagnosed with bacterial hepatobiliary infections from 3 referral centers in the United Kingdom from a denominator cohort of 71 036 dogs.

Retrospective multicenter study. Prevalence of dogs diagnosed with bacterial hepatobiliary infections was calculated. Odds ratios were calculated to establish breed predispositions. Signalment, clinicopathologic results, imaging abnormalities, bacterial culture results, gallbladder histology, treatment, and outcomes were reported.

Overall prevalence was 0.15% (95% CI, 0.12-0.18). Miniature Schnauzers (OR 8.95, 95% CI, 4.36-18.35, P < .0001) and Border terriers (OR 3.21, 95% CI, 1.06-9.70, P = .04) were predisposed for bacterial hepatobiliary infection compared to crossbreed dogs. Escherichia coli (70/156, 44.9%) and Enterococcus species (26/156, 16.7%) were the most frequently cultured isolates. More than 1 isolate was cultured in 33 out of 114 (28.9%) dogs. Of isolates with available susceptibility data, 55 out of 123 (44.7%) were multidrug resistant (MDR); 36 out of 123 (29.3%) were resistant to at least one fluoroquinolone, and 20 out of 123 (16.3%) were resistant to amoxicillin-clavulanate when first detected.

Breed predispositions for bacterial hepatobiliary infections have been identified for Miniature Schnauzers and Border terriers. A notable proportion of bacterial isolates were MDR at first detection, but most were susceptible to amoxicillin-clavulanate.

## Linked entities

- **Species:** Canis lupus familiaris (taxon 9615)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 488629], ALPL (alkaline phosphatase, biomineralization associated) [NCBI Gene 403548] {aka ALP}, PNLIPRP1 (pancreatic lipase related protein 1) [NCBI Gene 404010] {aka PLRP1}
- **Diseases:** endocarditis (MESH:D004696), aspiration pneumonia (MESH:D011015), congestive heart failure (MESH:D006333), Bacterial hepatobiliary infections (MESH:D001424), epitheliotrophic lymphoma (MESH:D008223), enteric inflammation (MESH:D004751), parasitic granuloma:1 (MESH:D006099), dysfunction (MESH:D006331), biliary obstruction (MESH:D001658), cCholangitis:2 (MESH:D020803), gallbladder carcinoid (MESH:D002276), Hepatic abnormalities (MESH:D056486), lipogranulomas:1 (MESH:C538557), necrosis (MESH:D009336), septic (MESH:D001170), biliary and arterial hyperplasia (MESH:D006965), corneal ulcers (MESH:D003320), septic shock (MESH:D012772), Cholelithiasis (MESH:D002769), chronic enteropathies (MESH:D002908), immune-mediated polyarthritis (MESH:D001168), biliary hyperplasia:1 (MESH:C537027), portal hypertension (MESH:D006975), hypothyroidism (MESH:D007037), death (MESH:D003643), encephalopathy (MESH:D001927), hepatopathy (MESH:D020754), bile peritonitis (MESH:D010538), aCholangiohepatitis:14 (MESH:C535488), cholestasis (MESH:D002779), Endocrinopathies (MESH:C567425), biliary infection (MESH:D007239), microvascular hepatopathy:1 (OMIM:603933), hepatobiliary disease (MESH:D004066), weight loss (MESH:D015431), neurological disease (MESH:D020271), hemorrhage (MESH:D006470), multiple organ dysfunction syndrome (MESH:D009102), biliary diseases (MESH:D001660), immune-mediated disease (MESH:C567355), Chronic cholecystitis (MESH:D002764), acute kidney injury (MESH:D058186), hepatoid gland carcinoma (MESH:D004701), hypoglycemic collapse (MESH:C000721848), jejunal adenocarcinoma (MESH:D007580), extrahepatic biliary duct obstruction (MESH:D001651), GBM (MESH:D009078), cholangitis (MESH:D002761), adrenal mass (MESH:C536030), vacuolar hepatopathy (MESH:C536522), gallbladder (MESH:D005705), hyperadrenocorticism (MESH:D000308), hyperlipidemia (MESH:D006949), fibrosis (MESH:D005355), abscess:2 (MESH:D000038), chronic hepatitis (MESH:D006521), chronic liver disease (MESH:D008107), hepatic abscesses (MESH:D008100), mast cell tumor (MESH:D007946), lameness (MESH:D007794)
- **Chemicals:** UDCA (MESH:D014580), prednisolone (MESH:D011239), silybin (MESH:D000077385), 1,2-o-dilauryl-rac-glycero-3-glutaric acid-(6'-methylresorufin) ester (-), carboplatin (MESH:D016190), dexamethasone (MESH:D003907), fluoroquinolone (MESH:D024841), SAMe (MESH:D012436), copper (MESH:D003300), vinorelbine (MESH:D000077235), cholesterol (MESH:D002784), mitoxantrone (MESH:D008942), chlorambucil (MESH:D002699), amoxicillin-clavulanate (MESH:D019980), Bilirubin (MESH:D001663), azathioprine (MESH:D001379)
- **Species:** Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Homo sapiens (human, species) [taxon 9606], Felis catus (cat, species) [taxon 9685], Enterococcus (genus) [taxon 1350], Clostridium perfringens (species) [taxon 1502], Escherichia coli (E. coli, species) [taxon 562], Canis lupus familiaris (dog, subspecies) [taxon 9615]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12952289/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12952289/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12952289/full.md

---
Source: https://tomesphere.com/paper/PMC12952289